Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-071612
Filing Date
2010-03-30
Accepted
2010-03-30 16:53:33
Documents
13
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR THE FISCAL YEAR ENDED DECEMBER 31, 2009 d10k.htm 10-K 1365781
2 SUBSIDARIES OF THE REGISTRANT dex211.htm EX-21.1 684
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 5560
4 CERTIFICATION OF THE COMPANY'S CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 9763
5 CERTIFICATION OF THE COMPANY'S CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 9914
6 CERTIFICATION OF THE COMPANY'S CEO AND CFO PURSUANT TO SECTION 906 dex321.htm EX-32.1 4087
7 GRAPHIC g68365g13l58.jpg GRAPHIC 54738
8 GRAPHIC g68365g22k63.jpg GRAPHIC 36502
9 GRAPHIC g68365g57l84.jpg GRAPHIC 33002
10 GRAPHIC g68365g61o87.jpg GRAPHIC 36067
11 GRAPHIC g68365g71g52.jpg GRAPHIC 45041
12 GRAPHIC g68365g88i65.jpg GRAPHIC 33486
13 GRAPHIC g68365g93f89.jpg GRAPHIC 42071
  Complete submission text file 0001193125-10-071612.txt   1785393
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Filer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51967 | Film No.: 10714534
SIC: 2834 Pharmaceutical Preparations